Drugmaker GlaxoSmithKline Plc said on Monday the China Food and Drug Administration (CFDA) has approved its human papillomavirus (HPV) vaccine, Cervarix, for use in the country to help women fight cervical cancer.
Source: Asia Pacific
Tags apple
Check Also
China denies its bomber aircraft on high state of alert amid North Korea tensions
China’s Defence Ministry on Friday denied reports that its bomber aircraft were on a heightened …